Connor, Clark & Lunn Investment Management (CC&L)’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1M | Buy |
124,245
+57,139
| +85% | +$14.7M | 0.11% | 159 |
|
|
2025
Q1 | $15M | Buy |
67,106
+5,166
| +8% | +$1.16M | 0.07% | 243 |
|
|
2024
Q4 | $14.2M | Buy |
61,940
+38,346
| +163% | +$8.77M | 0.06% | 238 |
|
|
2024
Q3 | $5.76M | Buy |
23,594
+19,184
| +435% | +$4.68M | 0.03% | 402 |
|
|
2024
Q2 | $844K | Buy |
4,410
+3,199
| +264% | +$612K | ﹤0.01% | 890 |
|
|
2024
Q1 | $240K | Sell |
1,211
-95,507
| -99% | -$18.9M | ﹤0.01% | 1347 |
|
|
2023
Q4 | $16.6M | Sell |
96,718
-126,292
| -57% | -$21.7M | 0.08% | 203 |
|
|
2023
Q3 | $33M | Buy |
223,010
+219,402
| +6,081% | +$32.4M | 0.17% | 113 |
|
|
2023
Q2 | $788K | Buy |
+3,608
| New | +$788K | ﹤0.01% | 865 |
|
|
2022
Q3 | – | Sell |
-1,023
| Closed | -$214K | – | 1229 |
|
|
2022
Q2 | $214K | Sell |
1,023
-662
| -39% | -$138K | ﹤0.01% | 922 |
|
|
2022
Q1 | $409K | Buy |
+1,685
| New | +$409K | ﹤0.01% | 818 |
|
|
2021
Q3 | – | Sell |
-14,030
| Closed | -$3.46M | – | 1197 |
|
|
2021
Q2 | $3.46M | Sell |
14,030
-8,888
| -39% | -$2.19M | 0.02% | 433 |
|
|
2021
Q1 | $4.45M | Buy |
22,918
+4,419
| +24% | +$857K | 0.02% | 384 |
|
|
2020
Q4 | $3.93M | Buy |
18,499
+3,835
| +26% | +$815K | 0.02% | 388 |
|
|
2020
Q3 | $2.51M | Buy |
+14,664
| New | +$2.51M | 0.02% | 434 |
|
|
2020
Q2 | – | Sell |
-14,593
| Closed | -$2.15M | – | 1156 |
|
|
2020
Q1 | $2.15M | Buy |
+14,593
| New | +$2.15M | 0.02% | 402 |
|
|
2018
Q3 | – | Sell |
-10,625
| Closed | -$1.1M | – | 1086 |
|
|
2018
Q2 | $1.1M | Buy |
+10,625
| New | +$1.1M | 0.01% | 592 |
|